CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers

Doxorubicin and Cisplatin are the frontline therapeutics for treatment of the triple negative breast cancers (TNBCs). Emergence of drug-resistance often contributes to failure of drugs and poor prognosis, and thus necessitates development of new and improved modalities to treat TNBCs. We generated a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Cheriyan, Vino T., Muthu, Magesh, Patel, Ketan, Sekhar, Sreeja, Rajeswaran, Walajapet, Larsen, Scott D., Polin, Lisa, Levi, Edi, Singh, Mandip, Rishi, Arun K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341985/
https://ncbi.nlm.nih.gov/pubmed/27687593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12333
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia